International Online Medical Council (IOMC)

Citations Report

Journal of Multiple Sclerosis : Citations & Metrics Report

Articles published in Journal of Multiple Sclerosis have been cited by esteemed scholars and scientists all around the world. Journal of Multiple Sclerosis has got h-index 11, which means every article in Journal of Multiple Sclerosis has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Multiple Sclerosis.

Journal of Multiple Sclerosis has got h-index 11, which means every article in Journal of Multiple Sclerosis has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Multiple Sclerosis.

	2022	2021	2020	2019	2018
Total published articles	50	59	6	3	9
Conference proceedings	0	0	0	0	0
Citations received as per Google Scholar, other indexing platforms and portals	54	59	46	57	43

Journal total citations count	521
Journal impact factor	2.30
Journal 5 years impact factor	2.28
Journal cite score	1.96
Journal h-index	11
Journal h-index since 2019	9

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
CiteScore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important Citations

Cavallo, S. (2020). Immune-mediated genesis of multiple sclerosis. Journal of Translational Autoimmunity, 3, 100039. View at Publisher View at Google Scholar
Katsavos, S., Artemiadis, A., Davaki, P., Stamboulis, E., Kilindireas, K., & Anagnostouli, M. (2018). Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease. Clinical neurology and neurosurgery, 173, 144-149. View at Publisher View at Google Scholar
Stamatelos, P., & Anagnostouli, M. (2017). HLA-genotype in multiple sclerosis: the role in disease onset, clinical course, cognitive status and response to treatment: a clear step towards personalized therapeutics. Immunogenet open access, 2(1), 1-12. View at Publisher View at Google Scholar
Gianfrancesco, M. A., Stridh, P., Shao, X., Rhead, B., Graves, J. S., Chitnis, T., ... & Network of Pediatric Multiple Sclerosis Centers. (2018). Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis Journal, 24(14), 1825-1834. View at Publisher View at Google Scholar
Bruno, A., Ronchey, S., Califano, L., Attanasio, G., Minni, A., Cavazzuti, P. P., ... & Mangialardi, N. 27Chronic cerebrospinal venous insufficiency and Meniere disease. View at Publisher View at Google Scholar
Kalodimou, V. E. (2014). Multiple Sclerosis & Research. J Mult Scler, 1(107), 2. View at Publisher View at Google Scholar
Khatri, B. O., Tarima, S., McQuillen, M. P., Kramer, J., & Dukic, M. (2014). Plasma Exchange in Secondary Progressive Multiple Sclerosis. View at Publisher View at Google Scholar
Andersen, J. B., Wandall-Holm, M. F., Andersen, P. K., Sellebjerg, F., & Magyari, M. (2021). Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort. Multiple Sclerosis Journal, 13524585211057767. View at Publisher View at Google Scholar
Andersen, J. B., & Magyari, M. (2020). Pharmacotherapeutic considerations in women with multiple sclerosis. Expert Opinion on Pharmacotherapy, 21(13), 1591-1602. View at Publisher View at Google Scholar
D’Amico, E., Leone, C., & Patti, F. (2016). Offspring number does not influence reaching the disability’s milestones in multiple sclerosis: a seven-year follow-up study. International journal of molecular sciences, 17(2), 234. View at Publisher View at Google Scholar
Vaughn, C., Bushra, A., Kolb, C., & Weinstock-Guttman, B. (2018). An update on the use of disease-modifying therapy in pregnant patients with multiple sclerosis. CNS drugs, 32(2), 161-178. View at Publisher View at Google Scholar
Coyle, P. K., Oh, J., Magyari, M., Oreja-Guevara, C., & Houtchens, M. (2019). Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review. Multiple sclerosis and related disorders, 32, 54-63. View at Publisher View at Google Scholar
Coyle, P. K. (2014). Multiple sclerosis in pregnancy. CONTINUUM: Lifelong Learning in Neurology, 20(1), 42-59. View at Publisher View at Google Scholar
Sandberg-Wollheim, M., Neudorfer, O., Grinspan, A., Weinstock-Guttman, B., Haas, J., Izquierdo, G., ... & Coyle, P. K. (2018). Pregnancy outcomes from the branded glatiramer acetate pregnancy database. International journal of MS care, 20(1), 9-14. View at Publisher View at Google Scholar
Motamedi, M. H. K., & Danial, Z. (2014). Journal of Multiple Sclerosis. View at Publisher View at Google Scholar
Khan M, Zahoor I, Haq EU (2015) Human Immunodeficiency Virus and Multiple Sclerosis Risk: Probing for a Connection. J Mult Scler 2(1000141): 376-0389. View at Publisher View at Google Scholar
Sánchez Morales C (2017) Alteraciones motoras, cognitivas y emocionales en la encefalomielitis autoinmune experimental. View at Publisher View at Google Scholar
Ludwig M, Turel AP, Zagon IS, McLaughlin PJ (2016) Take a look at the Recent articles. View at Publisher View at Google Scholar
Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2016) Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis. Multiple Sclerosis Journal–Experimental, Translational and Clinical 2: 2055217316672242. View at Publisher View at Google Scholar
Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2015) Treatment of clinically isolated syndrome and low dose naltrexone. Clin Case Reports Rev 1: 182-184. View at Publisher View at Google Scholar
Prev 1 2 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 Next »

Journal of Multiple Sclerosis

Citations Report

Journal of Multiple Sclerosis : Citations & Metrics Report

Important Citations

Cavallo, S. (2020). Immune-mediated genesis of multiple sclerosis. Journal of Translational Autoimmunity, 3, 100039.

Katsavos, S., Artemiadis, A., Davaki, P., Stamboulis, E., Kilindireas, K., & Anagnostouli, M. (2018). Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease. Clinical neurology and neurosurgery, 173, 144-149.

Stamatelos, P., & Anagnostouli, M. (2017). HLA-genotype in multiple sclerosis: the role in disease onset, clinical course, cognitive status and response to treatment: a clear step towards personalized therapeutics. Immunogenet open access, 2(1), 1-12.

Gianfrancesco, M. A., Stridh, P., Shao, X., Rhead, B., Graves, J. S., Chitnis, T., ... & Network of Pediatric Multiple Sclerosis Centers. (2018). Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis Journal, 24(14), 1825-1834.

Bruno, A., Ronchey, S., Califano, L., Attanasio, G., Minni, A., Cavazzuti, P. P., ... & Mangialardi, N. 27Chronic cerebrospinal venous insufficiency and Meniere disease.

Kalodimou, V. E. (2014). Multiple Sclerosis & Research. J Mult Scler, 1(107), 2.

Khatri, B. O., Tarima, S., McQuillen, M. P., Kramer, J., & Dukic, M. (2014). Plasma Exchange in Secondary Progressive Multiple Sclerosis.

Andersen, J. B., Wandall-Holm, M. F., Andersen, P. K., Sellebjerg, F., & Magyari, M. (2021). Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort. Multiple Sclerosis Journal, 13524585211057767.

Andersen, J. B., & Magyari, M. (2020). Pharmacotherapeutic considerations in women with multiple sclerosis. Expert Opinion on Pharmacotherapy, 21(13), 1591-1602.

D’Amico, E., Leone, C., & Patti, F. (2016). Offspring number does not influence reaching the disability’s milestones in multiple sclerosis: a seven-year follow-up study. International journal of molecular sciences, 17(2), 234.

Vaughn, C., Bushra, A., Kolb, C., & Weinstock-Guttman, B. (2018). An update on the use of disease-modifying therapy in pregnant patients with multiple sclerosis. CNS drugs, 32(2), 161-178.

Coyle, P. K., Oh, J., Magyari, M., Oreja-Guevara, C., & Houtchens, M. (2019). Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review. Multiple sclerosis and related disorders, 32, 54-63.

Coyle, P. K. (2014). Multiple sclerosis in pregnancy. CONTINUUM: Lifelong Learning in Neurology, 20(1), 42-59.

Sandberg-Wollheim, M., Neudorfer, O., Grinspan, A., Weinstock-Guttman, B., Haas, J., Izquierdo, G., ... & Coyle, P. K. (2018). Pregnancy outcomes from the branded glatiramer acetate pregnancy database. International journal of MS care, 20(1), 9-14.

Motamedi, M. H. K., & Danial, Z. (2014). Journal of Multiple Sclerosis.

Khan M, Zahoor I, Haq EU (2015) Human Immunodeficiency Virus and Multiple Sclerosis Risk: Probing for a Connection. J Mult Scler 2(1000141): 376-0389.

Sánchez Morales C (2017) Alteraciones motoras, cognitivas y emocionales en la encefalomielitis autoinmune experimental.

Ludwig M, Turel AP, Zagon IS, McLaughlin PJ (2016) Take a look at the Recent articles.

Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2016) Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis. Multiple Sclerosis Journal–Experimental, Translational and Clinical 2: 2055217316672242.

Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2015) Treatment of clinically isolated syndrome and low dose naltrexone. Clin Case Reports Rev 1: 182-184.

Journal Highlights

Journal Flyer

+44-73-6204-9920